New Online Video Shows Experimental System Using NaturalNano's Halloysite Nanotubes to Isolate Circulating Tumor Cells From Blood

(Nanowerk News) NaturalNano, Inc today announced that a free online video showing the step-by-step method to isolate circulating tumor cells from blood using microtubes lined with halloysite nanotubes (HNT) is available at
Dr. Michael King, Associate Professor of Biomedical Engineering at Cornell University, has produced a video demonstrating how he used HNT lined microtubes to enhance the isolation of live circulating tumor cells (CTCs) from patient blood samples. The nanotubes, when added to the surface of polymer tubing and then coated with adhesion proteins, is a straightforward and effective way for biomedical labs to capture CTCs from blood. The cells can then be placed in culture or characterized through standard assays.
Dr. King states "The ability to create stable coatings of halloysite using an extremely thin layer of poly-L-lysine gives us a way to create nanostructured surfaces that living cells respond to. This breakthrough could impact a number of projects we have been working on for basic research and diagnostic detection of circulating tumor cells in blood."
James Wemett, NaturalNano CEO, said "We believe that the video will be very useful in educating our customers, researchers, investors, the media and other interested parties as to the long-term potential of the HNT business. In addition, NaturalNano has established on our website a portal to purchase samples of Halloysite for use in research."
About NaturalNano
NaturalNano, Inc. is a materials science company focused on developing and commercializing advanced nanocomposites. The Company is focused on additive technologies and processes, including its proprietary Pleximer that adds value to industrial polymers, plastics and composites. NaturalNano holds and/or licenses 20 patents and applications relating to Halloysite, as well as proprietary know-how for its extraction and separation processes, compositions, and derivatives.
Source: NaturalNano (press release)
Subscribe to a free copy of one of our daily
Nanowerk Newsletter Email Digests
with a compilation of all of the day's news.
These articles might interest you as well: